Clinical Trial Update: HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial HER2HEART-US investigates prevention of cardiotoxicity in breast cancer patients receiving HER2-directed therapy; the study is currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Washington University School of Medicine | Conditions: HER2-positive Breast Cancer, HER2+ Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING